FDA Issues Draft Guidance, Updates Staff Manual to Speed ANDA Reviews

Drug Industry Daily
In a move aimed at speeding reviews of generics this year, the FDA released a new draft guidance on ANDAs for public comment along with an updated Manual of Policies and Procedures (MAPP) for agency staff that went into immediate effect.

To View This Article:


Subscribe To Drug Industry Daily